Kisho is an information platform, not a medical provider. Nothing on this site constitutes medical advice, diagnosis, or treatment recommendations. All content is aggregated from publicly available sources (including ClinicalTrials.gov, PubMed, FDA.gov, and Orphanet) and is provided for informational purposes only. Clinical trial eligibility, treatment decisions, and any health-related actions should always be discussed with a qualified healthcare professional. Kisho does not endorse any specific therapy, organization, or clinical trial. Terms of use · Privacy policy
An invasive cystic adenocarcinoma arising from the ovary. It is characterized by the presence of malignant glandular epithelial cells which contain intracytoplasmic mucin. The malignant cells invade the ovarian stroma and the cystic spaces contain mucoid material. In a minority of cases both ovaries are involved by the tumor. The prognosis for stage I tumors is excellent. Patients with metastases usually have a poor prognosis.
3 clinical trials registered. Interventions under study include drug therapy, other interventions, and biologic therapy. Pipeline includes 1 PHASE3, 1 PHASE2, 1 PHASE1. Research is primarily sponsored by academic and government institutions.
23 publications have been identified in PubMed for ovarian mucinous cystadenocarcinoma. Research spans Case Report / Case Series (83%), Other (4%), and Review / Meta-Analysis (4%).
Research Type | Count | % of Total |
|---|---|---|
Patient case studies | 19 |
Data assembled from 3 of 12 sources · Last updated Sep 20, 2026, 5:32 PM UTC
Other research | 1 | 4% |
Research summaries | 1 | 4% |
Laboratory research | 1 | 4% |
New treatment approaches | 1 | 4% |
Jarathi A (2026). [PMID: 41859198](https://pubmed.ncbi.nlm.nih.gov/41859198/). *Oncoscience*. [Case Report / Case Series]
Chui MH (2026). [PMID: 41397226](https://pubmed.ncbi.nlm.nih.gov/41397226/). *Int J Gynecol Pathol*. [Other]
Suri A (2026). [PMID: 41765224](https://pubmed.ncbi.nlm.nih.gov/41765224/). *Journal of pediatric and adolescent gynecology*. [Case Report / Case Series]
Shi H (2026). [PMID: 42058945](https://pubmed.ncbi.nlm.nih.gov/42058945/). *Int J Womens Health*. [Case Report / Case Series]
Benichou J (2025). [PMID: 40933177](https://pubmed.ncbi.nlm.nih.gov/40933177/). *Gynecol Oncol Rep*. [Case Report / Case Series]
Rose BD (2025). [PMID: 40551922](https://pubmed.ncbi.nlm.nih.gov/40551922/). *Cureus*. [Case Report / Case Series]
Xu C (2025). [PMID: 41276673](https://pubmed.ncbi.nlm.nih.gov/41276673/). *Virchows Archiv : an international journal of pathology*. [Basic Science / Preclinical]
Tien CT (2025). [PMID: 39854754](https://pubmed.ncbi.nlm.nih.gov/39854754/). *Medicine*. [Case Report / Case Series]
Wan X (2025). [PMID: 39902234](https://pubmed.ncbi.nlm.nih.gov/39902234/). *Frontiers in oncology*. [Case Report / Case Series]
Nusretoğlu R (2025). [PMID: 41716712](https://pubmed.ncbi.nlm.nih.gov/41716712/). *Frontiers in oncology*. [Case Report / Case Series]
AI-curated news mentioning ovarian mucinous cystadenocarcinoma
Updated Feb 27, 2026
A case report details bilateral ovarian mucinous cystadenocarcinoma in an adolescent girl, contributing to the understanding of this rare cancer type. This report may provide insights into diagnosis and treatment options for similar cases.